193 related articles for article (PubMed ID: 28918097)
1. Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors.
Li J; Wu F; Liu X; Zou Y; Chen H; Li Z; Zhang L
Eur J Med Chem; 2017 Nov; 140():20-30. PubMed ID: 28918097
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and bioevaluation of 1-phenylimidazole-4-carboxylic acid derivatives as novel xanthine oxidoreductase inhibitors.
Zhou H; Li X; Li Y; Zhu X; Zhang L; Li J
Eur J Med Chem; 2020 Jan; 186():111883. PubMed ID: 31761385
[TBL] [Abstract][Full Text] [Related]
3. Targeting the subpocket in xanthine oxidase: Design, synthesis, and biological evaluation of 2-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives.
Zhang B; Dai X; Bao Z; Mao Q; Duan Y; Yang Y; Wang S
Eur J Med Chem; 2019 Nov; 181():111559. PubMed ID: 31376568
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and bioevaluation of 2-phenyl-4-methyl-1,3-selenazole-5-carboxylic acids as potent xanthine oxidase inhibitors.
Guan Q; Cheng Z; Ma X; Wang L; Feng D; Cui Y; Bao K; Wu L; Zhang W
Eur J Med Chem; 2014 Oct; 85():508-16. PubMed ID: 25113879
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors.
Mao Q; Dai X; Xu G; Su Y; Zhang B; Liu D; Wang S
Eur J Med Chem; 2019 Nov; 181():111558. PubMed ID: 31369933
[TBL] [Abstract][Full Text] [Related]
6. Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic acid]: a potent xanthine oxidoreductase inhibitor with hepatic excretion.
Fukunari A; Okamoto K; Nishino T; Eger BT; Pai EF; Kamezawa M; Yamada I; Kato N
J Pharmacol Exp Ther; 2004 Nov; 311(2):519-28. PubMed ID: 15190124
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 1-hydroxy/methoxy-4-methyl-2-phenyl-1H-imidazole-5-carboxylic acid derivatives as non-purine xanthine oxidase inhibitors.
Chen S; Zhang T; Wang J; Wang F; Niu H; Wu C; Wang S
Eur J Med Chem; 2015 Oct; 103():343-53. PubMed ID: 26363870
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors with hypouricemic effects.
Yang Y; Yan D; Cheng H; Nan G; Hou X; Ren L; Yang Y; Li X; Tian J; Ye F; Xiao Z
Bioorg Chem; 2022 Dec; 129():106162. PubMed ID: 36183564
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 1-phenyl-1H-1,2,3-triazole-4-carboxylic acid derivatives as xanthine oxidase inhibitors.
Zhang TJ; Wu QX; Li SY; Wang L; Sun Q; Zhang Y; Meng FH; Gao H
Bioorg Med Chem Lett; 2017 Aug; 27(16):3812-3816. PubMed ID: 28693909
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1.
Yang C; Cai H; Zhu X; Zhang L; Li J
Eur J Med Chem; 2024 May; 271():116407. PubMed ID: 38663283
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitors of xanthine oxidoreductase].
Okamoto K
Nihon Rinsho; 2008 Apr; 66(4):748-53. PubMed ID: 18409526
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors.
Peng W; Liu F; Zhang L; Zhang L; Li J
Eur J Med Chem; 2023 Jan; 246():114947. PubMed ID: 36462435
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
Wang S; Yan J; Wang J; Chen J; Zhang T; Zhao Y; Xue M
Eur J Med Chem; 2010 Jun; 45(6):2663-70. PubMed ID: 20189693
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of novel xanthine oxidase inhibitors bearing a 2-arylbenzo[b]furan scaffold.
Tang HJ; Li W; Zhou M; Peng LY; Wang JX; Li JH; Chen J
Eur J Med Chem; 2018 May; 151():849-860. PubMed ID: 29684895
[TBL] [Abstract][Full Text] [Related]
15. Effects of cassia oil on serum and hepatic uric acid levels in oxonate-induced mice and xanthine dehydrogenase and xanthine oxidase activities in mouse liver.
Zhao X; Zhu JX; Mo SF; Pan Y; Kong LD
J Ethnopharmacol; 2006 Feb; 103(3):357-65. PubMed ID: 16182482
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site.
Sun M; Zhao J; Mao Q; Yan C; Zhang B; Yang Y; Dai X; Gao J; Lin F; Duan Y; Zhang T; Wang S
Bioorg Med Chem; 2021 May; 38():116117. PubMed ID: 33838610
[TBL] [Abstract][Full Text] [Related]
18. Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected].
Sato T; Ashizawa N; Matsumoto K; Iwanaga T; Nakamura H; Inoue T; Nagata O
Bioorg Med Chem Lett; 2009 Nov; 19(21):6225-9. PubMed ID: 19783139
[TBL] [Abstract][Full Text] [Related]
19. Effects of topiroxostat and febuxostat on urinary albumin excretion and plasma xanthine oxidoreductase activity in db/db mice.
Nakamura T; Murase T; Nampei M; Morimoto N; Ashizawa N; Iwanaga T; Sakamoto R
Eur J Pharmacol; 2016 Jun; 780():224-31. PubMed ID: 27038523
[TBL] [Abstract][Full Text] [Related]
20. Reducing effect of mangiferin on serum uric acid levels in mice.
Niu Y; Lu W; Gao L; Lin H; Liu X; Li L
Pharm Biol; 2012 Sep; 50(9):1177-82. PubMed ID: 22881143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
